In the News
FDA Warning Letter & Enforcement Trends of 2017: A Year in Review
ANDA
Preventing FDA Refuse-to-File Decisions for NDAs, ANDAs, and BLAs: A Quick Guide
Quality Systems
Assessing the Applicability and Necessity of CGMP to Drug Compounding
Good Manufacturing Processes
[Webinar Snippet] Key QMS Components for Compounding Pharmacy CGMP Compliance
Data Integrity
4 Ways Data Integrity is Being Improved in Clinical Research
In the News
5 Items on FDA's 2018 Regulatory Agenda
Quality Systems
Quality System Centralization vs. Decentralization: The Pros & Cons
In the News
FDA Makes Changes to Priority ANDA Draft Guidance
Risk Management
3 Key Areas to Assess When Integrating an Incoming Quality System
The FDA Group sets itself apart from traditional consulting firms through its client success and satisfaction rate, and its dedication to the life sciences.